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Physical activityAbstract Background: In North-African and Mediterranean countries (such as Algeria,
Tunisia, Morocco, Libya) no local 6-Min walk-distance (6MWD) norms exist for subjects aged
16–40 years.
Aims: (i) To test the applicability and reliability of the previously published norms for Arab or
Mediterranean subjects agedP 16 years in this population and, if required, (ii) to establish a
6MWD reference equation for use in North-African subjects aged 16–40 years and prospectively
assess its reliability and to propose a clear scheme to interpret the measured 6MWD.
Study design: Prospective cross-sectional study.
Methods: Metabolic-equivalent-task (MET) walking, moderate, and vigorous activities, anthro-
pometric, spirometric and 6-Min walk-test (6MWD, heart-rate, oxy-haemoglobin-saturation) data
were measured/noted in 200 healthy Algerian subjects aged 16–40 years (100 women). Univariate
and multiple linear regression analyses were used to find-out 6MWD influencing factors, reference
equation and to determine the lower-limit-of-normal (LLN).c-blood-
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350 M.K. Bourahli et al.Results: The mean ± SD of 200 included subjects’ age, height, weight, body-mass-index (BMI),
lean-mass, first-second-forced-expiratory-volume (FEV1) and MET moderate activity were, respec-
tively, 27.5 ± 6.7 years, 169 ± 9 cm, 69.3 ± 11.5 kg, 24.1 ± 3.6 kg/m2, 16.7 ± 7.4 kg, 3.70
± 0.74 L and 370 ± 686 min/week. Their 6MWD mean ± SD (minimum–maximum) was 680
± 70 (540–888) m. The published norms for Italian and Saudi-Arabian populations did not reliably
predict measured 6MWD. The following 6MWD influencing factors were noted: FEV1, BMI, sex,
lean-mass, MET moderate activity and age (p< 0.001). A reference equation, explaining 58.7% of
the 6MWD variability, was established: 6MWD (m) = 800.05 + 64.71  Sex (men:1/women:0) 
10.23  BMI (kg/m2)  1.63  Age (years) + 2.05 Weight (kg). To calculate the 6MWD LLN
subtract 74.31 m from the predicted value. In a second group of 39 young subjects (19 women)
prospectively studied to validate the reference equation, the agreement between the measured
and predicted 6MWDs was adequate.
Conclusion: This reliable 6MWD norm is helpful for the care of North-African patients aged 16–
40 years.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest
Diseases and Tuberculosis. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Exercise testing is increasingly utilized in clinical practice to
optimize patient management and acquire useful functional
and predictive information not accessible through static car-
diopulmonary tests, such as spirometry and/or electrocardio-
gram [1–5]. Among the available variety of exercise testing
protocols for this purpose; the 6-Min walk-test (6MWT) is
an inexpensive and expeditious test of functional ability [1–
4]. It is a self-based walking test that measures the distance
walked over a 6-Min period (6MWD) [1,3]. It is frequently
used to evaluate exercise capacity in patients with chronic dis-
eases [2–4,6–8]. The interpretation of this test, which is more
wistful of daily living activities than other walk tests [1–3],
relies on the comparison of measured 6MWD with the normal
predicted value from reference equations or norms [1,2,9–36].
Normal predicted values for 6MWD are often based on sex
and anthropometric data (eg, age, height and weight) [1,4] and
the influence of race and/or ethnicity is still ambiguous [1,18].
At the best of the authors knowledge, only three 6MWD
norms were published for healthy Arab ‘‘adults” populations
[9–11]; two for Tunisians older than 40 years [9,10] and one
for Saudi aged 16–50 years [11]. In addition, among all pub-
lished studies aiming to establish 6MWD norms in healthy
adults [9–36] only one included young Mediterranean ones;
Italians aged 20–50 years [12]. In North-African
Mediterranean countries (such as Algeria, Tunisia, Morocco,
Libya) no local 6MWD norms existed for subjects aged 16–
40 years and norms derived from Arab [11] or
Mediterranean [12] populations are commonly used. This
was the case of two recent studies aiming to evaluate the func-
tional capacity of exclusive-narghile-smokers [7] and
obstructive-sleep-apnoea-hypopnea-syndrome patients [8].
This is a problematic practice, since the applicability and trust-
worthiness of these norms has never been verified in the local
population, even though several specificities have been noted
concerning ethnic background, anthropometric data, physical
activity status, etc. [37]. The use of these 6MWD norms
[11,12] may lead to invalid clinical analysis of 6MWT data
[4,10,26]. In a multicenter study, the 6MWD norms varied in
function of the geographic site; therefore, different countries
need specific equations [26]. Moreover, the answer to thequestion of which 6MWT norm should be used in chronic-o
bstructive-pulmonary-disease (COPD) patients, was that the
choice should be specific for the country/region of origin
[38]. Furthermore, the American-Thoracic-Society/European-
Respiratory-Society (ATS/ERS) promote investigators to pub-
lish norms for healthy persons using the 6MWT guidelines
[1,3].
Although physical inactivity may lead to increased risk of
long-term disability and co-morbidity [24,39], the relationship
between the physical activity status and the 6MWD of healthy
subjects is controversial [10,11,14–16,24–26,30,31,33]. In some
studies [10,14], it was shown to correlate, albeit poorly, with
the 6MWD. Other studies [11,15,16,25,30,31,33] found no
significant correlations between the 6MWD and physical
activity status evaluated by several ways [40–43]. In addition,
in the study [24] applying the international-physical-activity-
questionnaire (IPAQ-8) [44], no data were reported about
the relationship between measured 6MWD and physical
activity levels’.
Yet, lean-mass is a predictor of exercise capacity in
healthy subjects [45], and at the best of the authors knowl-
edge, no study aiming to establish norms in healthy subjects
agedP 16 years [9–36] has evaluated its relationship with
measured 6MWD. This is a further criticism, because the
classical measured anthropometric data may not cover all
the important anthropometric information that may be
required to explain 6MWD variability’. In COPD, 6MWD
was similar in patients with and without lean-mass deple-
tion, indicating that the skeletal muscle has limited influence
on 6MWD [46]. Specific studies on the influence of lean-
mass on 6MWD of healthy adults are needed,
Making a medical judgment is an art, where test results
help to confirm or decline the diagnosis [47]. A test result
is regarded as well-matched with disease if it is outer to
the normal range [47]. In young subjects, the last can be
determined by three methods: tables of reference centile by
age-decade [23], calculating the lower-limit-of-normal
(LLN) [14,19,20,22,24] or fixing a percentage (81% of pre-
dicted value [15]) below which the 6MWD is considered
abnormal. In some studies [13,16–18,21], especially the
Saudi and the Mediterranean ones [11,12], no interpreting
scheme was proposed.
6MWT data in North-African subjects aged 16–40 years 351The aims of the present study were as follows:
(i) To determine the factors influencing 6MWD in healthy
Algerian adults aged 16–40 years, with particular atten-
tion to physical activity status and lean-mass.
(ii) To test the applicability and reliability of the previously
published norms for Arab [11] or Mediterranean [12]
subjects agedP 16 years in this population and, if
required.
(iii) To establish a 6MWD reference equation for use in
North-African subjects aged 16–40 years and prospec-
tively assess its reliability and to propose a clear scheme
to interpret the measured 6MWD.
Population and methods
This prospective study was performed over a 18-month period
at the clinical Physiology and Functional Exploration
Department of BEN BADIS Hospital in the Eastern region
of Algeria (Constantine region, 649 m above sea level).
Study design
Subjects agedP 18 years were recruited among local Hospital
and Medical School workers and/or students. Adolescents
aged 16–18 years were the offspring of Hospital and Medical
School workers. Informational letters clarifying the aims of
the study were put up at the Hospital departments and the
local Medical School.
The study was conducted in compliance with the ‘Ethical
principles for medical research involving Human subjects’ of
Helsinki Declaration (available from: http://www.wma.net/
en/30publications/30ethicsmanual/pdf/ethics_manual_arabic.
pdf, accessed June 19th; 2015). Approval for the study was
obtained from the Hospital ethics committee (approval num-
ber 2211/2013). The approval specifically covered the inclusion
of subject aged 16–18 years. Written informed consent was
obtained from all study participants agedP 18 years and from
the parents of included adolescents.
Data from each volunteer subject included: sex, age, height,
weight, body-mass-index (BMI), lean-mass, fat-free-mass
(FFM), smoking history, medication use, medical history,
physical examination, physical activity questionnaire and
spirometry data. The 6MWT was then performed. All subjects
received a copy of their tests results and when an unsuspected
dysfunction was revealed, they were sent to a specialist.
Sample size
The sample size estimation was based on the following formula
[48]: n= (Za/2)
2 s2/d2, where ‘‘s” (=52 m) is the 6MWD SD’
obtained from a Saudi-Arabian study [11] and ‘‘d” (=10 m) is
the accuracy of the estimate or how close to true mean. ‘‘Za/2”
is a normal deviate for two-tailed alternative hypothesis at a level
of significance (Za/2 is 2.58 for 1% level of significance). The
required number of subjects was estimated to be 180. This esti-
mated number was increased by 10% to account for attrition
and missing values. The final estimated number was 200.
To verify the reliability of the present study 6MWD norm,
6MWD was prospectively measured in a second group of 39additional healthy subjects (19 women) who met the study
inclusion-criteria and had not participated in the first part.
Subjects
Healthy volunteer subjects aged 16–40 years [49] were
included. Non-inclusion criteria were: ageP 40 years, the
usual 6MWT counter-indications [3] [unstable angina or
myocardial infarction during the preceding month; resting
heart-rate (Hrrest)]P 120 bpm, resting systolic- or diastolic-
blood-pressures (SBPrest, DBPrest), respectively P180 mmHg
and P100 mmHg], current or ex-smokers, symptoms of- or
confirmed cardiopulmonary disease [heart-failure or arrhyth-
mia, major electrocardiogram abnormalities, lower limb arteri-
tis, dyspnoea (modified medical research council scale)P stage
two, chronic cough, COPD, emphysema, asthma, wheezing,
interstitial fibrosis, pulmonary tuberculosis, cerebrovascular
accident], diabetes, thoracic or abdominal surgery, orthopae-
dic disease interfering with walking, mental disease, marked
and extreme obesity and chronic medication use (corticoids,
diuretics, adrenergic b-antagonists). Exclusion-criteria were:
incapability to perform exactly the 6MWT, large-airways-
ventilatory-obstructive-defect (LAOVD), tendency-to-a-restric
tive-ventilatory-defect (TRVD), resting oxy-haemoglobin-
saturation (oxy-satrest) 692%, end 6MWT dyspnoea (visual-
analogue-scale) >5/10 and walking induced desaturation
(oxy-sat fall > 5 points).Medical and physical activity questionnaires
A medical questionnaire recommended for epidemiological
investigation was used to assess numerous subject characteris-
tics [50].
Physical activity was evaluated using the IPAQ-8 short
version (www.ipaq.ki.se/scoring.pdf, accessed June 19th,
2015) [44]. It includes questions about duration and intensity
of physical activity on a ‘‘usual” week in occupational, trans-
port, leisure or sport activities. A French version of the
IPAQ-8 was filled out by each subject, and metabolic-
equivalent-task (MET) walking, moderate, and vigorous
activities were evaluated to yield a MET total activity score,
(min/week). Three levels (low, moderate and high) of physical
activity were identified [44] and two physical activities sta-
tuses [active (high physical activity level); non-active (low
and moderate physical activity levels)] were arbitrarily
identified.
Physical examination
The decimal age was calculated to the nearest 0.01 years from
the date of measurement and the date of birth. Height (±1 cm)
was measured with a height gauge (standing stadiometre type
DETECTO) with shoes removed, heels joined, and back
straight. Weight (±1 kg) and FFM (kg) was measured using
an impedance metre (TANITA Corporation 1-14-2, Maeno-
Cho, Itabashi-ku Tokyo Japan). Lean-mass (weight – FFM)
and BMI (weight/height2) were calculated.
The following definitions were adopted [51]: underweight
(BMI < 18.5), normal weight (18.5 6 BMI 6 24.9), over-
weight (25.0 6 BMI 6 29.9), moderate obesity (30.0 <
352 M.K. Bourahli et al.BMI < 34.9); marked obesity (35.0 6 BMI 6 39.9) and
extreme obesity (BMIP 40.0).
Spirometry measurements
Spirometric measurements (ZAN 100, Megrera¨te GmbH,
Germany) were performed [52]. The results [first-second-force
d-expiratory-volume (FEV1), forced-vital-capacity (FVC),
FEV1/FVC and maximal-mid-expiratory-flow (MMEF)] were
compared with local spirometric norms [37]. LAOVD was
defined as a ‘‘FEV1/FVC ratio < LLN” [53]. A record with
‘‘FEV1 < LLN” and ‘‘FVC < LLN” and ‘‘FEV1/FVC >
LLN” was considered as a TRVD [54].
6MWT procedure
The 6MWT procedure was widely described in previous stud-
ies aiming to establish 6MWD norms for healthy North-
African children [55] or adults’P 40 years [10].
Two 6MWTs were supervised by the same physician
(MKB) according to international guidelines [3] 6MWTs were
made along a 30 m corridor marked every one metre with
cones to indicate turnaround points. To reduce intraday vari-
ability, temperature effects and biological rhythms, the 6MWT
was done between 8 a.m. and 12 noon, a period characterized
by a stable ambient temperature of 15–21 C. At the end of
each minute, subjects were given feedback on the elapsed time
and homogeneous encouragement in the form of statements
such as ‘‘you’re doing well,” and ‘‘do your best.” All subjects
performed the 6MWT for the first time with no warm-up phase
and they were told to avoid forceful exercise in the two hours
prior to testing and to wear comfortable clothes and suitable
walking shoes [10].
The subjects sat on a chair situated near the starting site for
at least ten minutes before the test started. During this time,
dyspnoea, Hr and oxy-sat (Medlab Nanox 2) and blood-
pressures were measured at rest (rest). The test directives to
the volunteers were those recommended by the ATS [3]. At
the end (end) of the 6MWT, the same data, in addition to
6MWD, were measured/noted. Hr was expressed as bpm and
as a percentage of predicted maximal-Hr [mHr = 208–
0.7  Age]. As recommended [3], the second 6MWT began
20–45 min after the first one, in order to achieve comparable
initial Hrrest [12–14,16,17,19].
Data analysis
The results of the 6MWT having the utmost 6MWD were
selected for statistical analysis [13,17,19]. Preliminary descrip-
tive analysis included frequencies for categorical variables.
The variables are presented as mean ± SD and 95%
confidence-interval (95%CI) if normally distributed or median
(1st–3rd quartiles) if skewed.
Univariate and multiple regression analysis (influencing factors)
The dependent variable (6MWD) was normally distributed.
T-tests were used to evaluate the associations between
6MWD and categorical variables (sex and physical activity sta-
tus) and Pearson product-moment correlation-coefficient (r)evaluated the associations between 6MWD and continuous
ones [height, age; weight, BMI, lean-mass, FFM, FEV1 (L),
FVC (L), MMEF (L/s), SBPrest, DBPrest, Hrrest and MET
walking, moderate and vigorous activity scores]. The linearity
of the relationship between 6MWD and the continuous data
was graphically verified by scheming each regressor against
6MWD. Only significantly and linearly associated data were
entered into the model. A linear regression model was used
to evaluate the independent data explaining the 6MWD vari-
ance. Candidate variables were stepped into the model with
a stepwise selection method. To determine entrance and elim-
ination from the model, significance levels of 0.15 and 0.05
were used, respectively. No colinearity between predictors
was noted with variance inflation factors.
Comparison with commonly used norms in young North-African
adults
S1 Table detailed Arabian and Mediterranean studies [11,12]
commonly used in North-African subjects aged 16–40 years.
Measured 6MWDs were compared with predicted ones
from the commonly used norms [11,12] for the same age
range as in the related study, in two ways. Limits-of-
agreement were used for comparison, with individual differ-
ence between measured and predicted 6MWD plotted against
the corresponding mean value [56]. From these data, limits-
of-agreement were then calculated (mean difference between
measured and predicted 6MWD± 1.96 SD) [56].
Comparisons also integrated paired t-tests between measured
and predicted values.
6MWD reference equations
According to guidelines [1,3], interpretation of the 6MWD
should preferably be made by considering age, height, weight
and sex, variables shown to independently influence healthy
subjects 6MWT data [9–17,19–36]. For this reason, norms
were established using those data as predictors of 6MWD in
other stepwise linear regression models. The latter were evalu-
ated by the determination-coefficient (r2) and the standard-
error.
The residual-SD (RSD= (measured 6MWD  predicted
6MWD)/SD of the predicted 6MWD) and the LLN
(=1.64  RSD) were calculated. A measured 6MWD lower
than the LLN was considered abnormal.Reliability of the simplified reference equation
As done in some studies [11,13,14], the reliability of the pre-
sent simplified 6MWD norm was evaluated in an additional
group of 39 healthy subjects. The measured 6MWDs were
compared with the predicted ones from the simplified
6MWD norm. The latter will be qualified as appropriate
for Algerian subjects aged 16–40 years, if no statistical signif-
icant difference will be found between predicted and mea-
sured 6MWD values and if no subject will have a measured
6MWD value < LLN.
All statistical procedures were performed using statistical
software (Statistica Kernel version 6; Stat Software. France).
Significance was set at the 0.05 level.
6MWT data in North-African subjects aged 16–40 years 353Results
An initial sample of 258 volunteers (120 women) was exam-
ined. Non-inclusion and exclusion-criteria were found in 19
subjects [smokers (n= 12), BMI > 35 kg/m2 (n= 5),
LAOVD and TRVD (n= 2)].
Approximately 84% of the studied population (n= 200)
was randomly selected for inclusion in a predictive equation,
while the remaining subjects (n= 39) were used as validation
group.
Demographic, anthropometric, spirometric and 6MWT data
The anthropometric and spirometric data and MET scores of
the included men (n= 100) were significantly different from
those of the women (n= 100), except for age, BMI, FEV1/
FVC, MMEF (%) and MET moderate activity (Table 1).
One hundred and eight subjects (48 women), ten (six women)
and nine (five women) showed, respectively, normal weight,
moderate obesity and underweight. Fourteen adolescents aged
16–18 years were included.
The 6MWT data are shown in Table 2. 6MWTs were well
tolerated and none of the 6MWTs were interrupted before
the 6-min mark. Wide 6MWD range (540–888 m) was noted
for the total sample. The total sample 6MWD is shown in S1
Fig. according to age, height and weight ranges.
Univariate analysis
Sex significantly influenced the 6MWD (Table 2). On average,
the 6MWD value was 92 m greater in men when compared to
women (p< 0.05).Table 1 Characteristics of the included healthy North-African subj
Women (n= 100)
Age (Year) 27.64 ± 6.45
Height (cm) 162 ± 5
Weight (kg) 64.13 ± 9.78
Fat-free-mass (kg) 42.65 ± 3.64
Lean-mass (kg) 20.59 ± 7.02
Body-mass-index (kg/m2) 24.0 ± 3.8
FVC (L) 3.58 ± 0.40
FVC (%pred) 88 ± 8
FEV1 (L) 3.10 ± 0.36
FEV1 (%pred) 88 ± 8
FEV1/FVC (absolute value) 0.87 ± 0.05 (0.86 to 0.88
MMEF (L/s) 3.64 ± 0.72
MMEF (%pred) 80 ± 14
MET walking activity m/w 803 ± 810
MET moderate activity m/w 446 ± 558
MET vigorous activity m/w 442 ± 669
MET total activity m/w 1691 ± 1221
Physical activity levels
Low participation 32 (32.0%)
Moderate participation 52 (52.0%)
High participation 16 (16.0%)
Data are mean ± SD except for the physical activity levels where data a
FEV1: first-second-forced-expiratory-volume. FVC: forced-vital-capacity.
mid-expiratory flow. pred: predicted.
* p< 0.05 (t-test): men vs. women.
# p< 0.05 (chi-2): men vs. women.On average, the 6MWD value was 36 m greater in active
subjects (n= 54) when compared to non-active ones
(n= 146) (p< 0.05).
S2 Table shows the r2 between the measured 6MWD and
subjects’ data. The total sample 6MWD was significantly cor-
related with age, height, FFM, lean-mass, BMI, FVC (L),
FEV1 (L), MMEF (L/s), MET walking, moderate, vigorous
and total activity scores, Hrrest and SBPrest.
Multiple regression analysis: Influencing factors
Table 3 presents the cumulative r2 of the independent influenc-
ing factors incorporated in the 6MWD linear multiple regres-
sions. Up to 62% of the total sample 6MWD variability’
could be explained by six variables: FEV1, BMI, sex, lean-
mass, MET moderate activity and age.
Comparison with published regression equations
Fig. 1 shows, for the same age range, the comparisons between
measured and predicted 6MWD from the Italian (Fig. 1A) and
Saudi (Fig. 1B) norms. There was a difference between mea-
sured and predicted 6MWD from these two norms, which was
always statistically significant. Indeed, mean ± SD measured
6MWD was significantly overestimated by 3 ± 45 m and was
significantly underestimated by 210 ± 58 m, respectively, with
the Mediterranean [12] and the Saudi [11] norms.
6MWD simplified norm
Due to the inadequacy of the commonly used norms [11,12] in
Algerian subjects aged 16–40 years, local adapted 6MWDects.
Men (n= 100) Total sample (n= 200)
27.39 ± 6.91 27.52 ± 6.67
177 ± 6* 169 ± 9
74.45 ± 10.70* 69.29 ± 11.46
59.89 ± 6.37* 51.03 ± 10.06
12.67 ± 5.41* 16.74 ± 7.42
23.9 ± 3.4 24.1 ± 3.6
5.05 ± 0.53* 4.32 ± 0.87
94 ± 9* 91 ± 9
4.30 ± 0.49* 3.70 ± 0.74
93 ± 9* 91 ± 9
) 0.85 ± 0.05 (0.84 to 0.86) 0.87 ± 0.05 (0.85 to 0.87)
4.63 ± 1.09* 4.12 ± 1.04
76 ± 16 78 ± 15
1679 ± 1952* 1239 ± 1552
292 ± 79 370 ± 686
795 ± 1250* 617 ± 1014
2767 ± 2373* 2226 ± 1955
21 (21.0%)# 53 (26.5%)
41 (41.0%) 93 (46.5%)
38 (38.0%)# 54 (27.0%)
re number (%).
m/w: min/week. MET: metabolic-equivalent-task. MMEF: maximal-
Table 2 6-Min walk-test (6MWT) data of the included healthy North-African subjects.
Women (n= 100) Men (n= 100) Total sample (n= 200)
Rest End Rest End Rest End
Heart-rate (bpm) 83 ± 10 140 ± 19 78 ± 10* 131 ± 21* 80 ± 10 135 ± 20
Heart-rate (%pred) 44 ± 5 74 ± 9 41 ± 5* 69 ± 11* 42 ± 5 72 ± 10
Systolic-blood-pressure (mmHg) 112 ± 11 138 ± 19 119 ± 11* 146 ± 17* 116 ± 11 142 ± 18
6MWD Measured (m) 634 ± 49 726 ± 55* 680 ± 70
Predicted (m) 637 ± 28 729 ± 25 683 ± 53
Measured (%pred) 100 ± 6 100 ± 7 100 ± 7
Oxy-haemoglobin saturation (%) 98 (96–98) 98 (96–98) 97 (96–98)* 97 (96–98)* 97 (96–98) 97 (96–98)
Diastolic-blood-pressure (mmHg) 70 (60–75) 60 (50–70) 70 (60–80)* 60 (50–70) 70 (60–80) 60 (50–70)
Data are mean ± SD for heart-rate, systolic-blood-pressure and 6MWD.
Data are median (1st–3rd quartiles) for oxy-haemoglobin saturation and diastolic-blood-pressure.
Heart-rate (%pred): heart-rate expressed as a percentage of the maximal predicted heart-rate. 6MWD: 6-Min walk-distance. 6MWD (%pred):
6MWD expressed as a percentage of the present study retained reference equation.
* p< 0.05: men vs. women.
Table 3 Independent variables included in the multiple regression models for the 6-Min walk-distance (6MWD).
Independent variables B 95% CI around B Cumulative r2 P level SE
Women (n = 100)
Constant 419.88 182.13 to 657.64 0.01 144.97
Body-mass-index (kg/m2) 3.38 5.38 to 1.37 0.219 0.02
FEV1 (L) 16.48 7.74 to 40.70 0.304 0.26
DBPrest (mmHg) 0.61 1.32 to 0.09 0.326 0.15
Height (cm) 2.01 0.44 to 3.57 0.345 0.03
Age (Year) 1.42 2.69 to 0.15 0.368 0.06
Men (n = 100)
Constant 813.71 702.44 to 924.98 0.02 67.85
Body-mass-index (kg/m2) 8.22 11.49 to 4.95 0.191 0.01
FEV1 (L) 28.77 12.33 to 45.22 0.281 0.01
MET moderate activity 0.01 0.02 to 0.00 0.307 0.04
Lean-mass (kg) 2.57 0.24 to 4.91 0.333 0.07
DBP (mmHg) 0.62 1.46 to 0.21 0.344 0.22
Total sample (n = 200)
Constant 698.04 633.91 to 762.18 0.01 39.11
FEV1 (L) 30.54 9.03 to 4.59 0.504 0.02
Body-mass-index (kg/m2) 6.84 17.52 to 43.55 0.569 0.01
Sex (men:1/women:0) 59.41 39.25 to 79.57 0.602 0.03
Lean-mass (kg) 1.60 0.29 to 2.92 0.610 0.04
MET moderate activity (m/w) 0.01 0.00 to 0.02 0.617 0.06
Age (Year) 0.73 1.66 to 0.19 0.620 0.19
95% CI: 95% confidence-interval. B: non standardized regression coefficient. DBP: diastolic-blood-pressure. FEV1: first-second-forced-expi-
ratory-volume. m/w: min/week. MET: metabolic-equivalent-task. P: probability. r2: determination-coefficient. SE: standard-error.
Proposed model for the total sample: 6MWD (m) = 698.04  6.84  body-mass-index + 30.54  FEV1 + 59.41  Sex + 1.60  Lean-mass
+ 0.01 MET moderate activity  0.73  Age.
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reading of 6MWD values, and as norms should incorporate
only simply measured anthropometric data [1,3], three simpli-
fied 6MWD norms with five common parameters (sex, BMI,
age, weight and height) were established for women, men
and total sample. The total sample single model [6MWD
(m) = 800.05 + 64.71  Sex (men:1/women:0)  10.23  BMI
(kg/m2)  1.63  Age (Year) + 2.05 Weight (kg)] appeared
to clarify 59% of the 6MWD variability. Therefore, it was
retained as the norm for Algerian subjects aged 16–40 years
(Table 4). After the predicted 6MWD value for an individualwas computed from this equation, the LLN could be obtained
by subtracting 74 m from predicted 6MWD values. The mea-
sured 6MWD corresponded to 100 ± 8% of the predicted
one. In addition, no subject showed a 6MWD <81% or
<LLN.
Reliability of the single simplified equation
The mean 6MWD prospectively measured in 19 women and 20
men (mean ± SD of age, height, weight and BMI, were respec-
tively, 28.78 ± 7.11 years, 169 ± 10 cm, 69.49 ± 13.29 kg and
Figure 1 Bland and Altman representation, for the same age
range, of measured and predicted 6-Min walk-distance (6MWD)
determined from the reference equations of Chetta al. [12] (A) and
Alameri et al. [11] (B). The correlation between mean difference
(Y-axis) and mean value (X-axis) is significant in all instances,
indicating a proportional error of 6MWD predicted with the
corresponding reference equation. r: correlation-coefficient. r2:
determination-coefficient. p: probability. n= number of subjects
of the present study in the age range. : Mean; : Mean ± 1.96
SD. : Regression line.
6MWT data in North-African subjects aged 16–40 years 35524.2 ± 3.8 kg/m2) was 686 ± 80 m, representing 101 ± 6%
(range: 91–119%) of the predicted value from the retained sim-
plified norm. The difference between prospectively measured
and predicted 6MWD was not significant (5 ± 44 m,
p= 0.46) and the correlation was significant (r= 0.85;
p< 0.01). In addition, no subject showed a 6MWD <81%
or <LLN.
Discussion
The 6MWD of a large group of healthy North-African sub-
jects aged 16–40 years was prospectively measured. In addition
to sex and common anthropometric data, the 6MWD
appeared to be influenced by lean-mass, spirometric and phys-
ical activity data. The Saudi and Italian norms, usually applied
in North-Africa, did not reliably predict 6MWD in Algerian
subjects aged 16–40 years. Thus, a new single norm explaining
59% of the 6MWD variability’ was established using sex,
BMI, age and weight as independent predictors. Finally, in a
second group of voluntary subjects prospectively evaluated,
the retained norm yielded satisfactory predictions.Given that 6MWD norms varied in function of the geo-
graphic site [26] and that the choice of the applied 6MWT
norm should be specific for the country/region of origin [38],
different countries need specific equations [26]. S3 Table
exposes the main characteristics of the studies aiming to estab-
lish 6MWD norms and including subjects aged 16–40 years
[11–24].
6MWT procedure
In a large group of healthy subjects aged 16–40 years, the
expected wide range in 6MWD (550–880 m) was found, in line
with similar studies (S3 Table). The average measured 6MWD
(680 ± 70 m) was relatively shorter than these measured in
Norwegian adults aged 18–49 years [24] and longer than those
measured in other populations [11–23] (S3 Table) especially the
Saudi and Italian ones [11,12] (S1 and S3 Tables). It is possible
that this discrepancy reflects differences in how 6MWT proto-
col (encouragement, motivation aspects’, corridor distance
varying from 15 m [18,24] to 45 m [12,23], etc.) was conducted,
applied inclusion and non-inclusion criteria, sample sizes, dif-
ferences in racial, demographic and anthropometric factors
(especially age ranges) of recruited adults’ in each study
[1,2,4,17,18]. Subjects’ submaximal effort could also be consid-
ered as a possibility.
Insofar as possible, the practical factors that affect 6MWT
variability [3] were controlled: 6MWT counter-indications
respect, understandable information, subjects preparation,
6MWT schedule, supervisor choice, control modalities, corri-
dor distance choice (30 m as done in other studies [11–
15,17,19,20,22,23]), encouragement standardization. Like in
some studies [11,13,14,17,18,23] two 6MWTs were performed.
The number of 6MWTs used for familiarization purposes var-
ied from one [20–22,24] to four [16]. These methodological pre-
cautions thus allowed us to obtain reliable results.
Subject group composition
Perfect samples are those that consist of persons randomly
selected among the general population [15]. Thus, a limitation
of this study, as all other studies [13–24], was the use of a
convenient sample. To account for this and as done by one
author [11] 84% of the sample individuals was randomized
to formulate the 6MWD reference equation. The lasting
16% were enrolled in the cross-validation study of the devel-
oped reference equation. This sampling method is able of dip-
ping the biases that are inherent to convenience sampling. In
addition, as done by some authors [13–17,19–24], much effort
was put into recruiting a representative sample of volunteers
subjects’, covering numerous economical activities and
recruited from diverse settings and geographical sites in
Constantine.
The calculated sample size (n= 200) was within the range
of most earlier studies with similar aims [higher than some
(from 79 [16] to 175 [19] adults) and lower than others (from
211 [21] to 617 [13] adults) (S3 Table). It is important to note
that among the 617 subjects included in the multicenter study
[13] only 221 were aged < 39 years. One strong point for the
present study, as done by a few authors [15,22–24], was the cal-
culation of the sample size which is a statistically crucial point
[48].
Table 4 Reference equations for the 6-Min walk-distance (6MWD).
Independent variables B P level Cumulative r2 SE LLN5%
Women (n = 100)
Constant 347.45 0.001 140.35 66.63
BMI (kg/m2) 3.68 0.002 0.219
Height (cm) 2.67 0.001 0.286
Age (Year) 2.03 0.004 0.345
Men (n = 100)
Constant 2417.08 0.02 1022.35 80.73
BMI (kg/m2) 41.96 0.06 0.191
Weight (kg) 11.63 0.09 0.210
Height (cm) 8.61 0.14 0.227
Age (Year) 1.24 0.16 0.243
Total sample (n = 200)
Constant 800.05 0.0001 22.55 74.31
Sex (men:1/women:0) 64.71 0.0001 0.437
BMI (kg/m2) 10.23 0.0001 0.550
Age (Year) 1.63 0.003 0.570
Weight (kg) 2.05 0.004 0.587
B: non standardized regression coefficient. BMI: body-mass-index. DBP: diastolic-blood-pressure. FEV1: first-second-forced-expiratory-vol-
ume. m/w: min/week. MET: metabolic-equivalent-task. P: probability. r2: determination-coefficient. SE: standard-error. LLN: lower-limit-of-
normal.
6MWD simplified reference equation for the total sample: 6MWD (m) = 800.05 + 64.71  Sex  10.23  BMI  1.63  Age
+ 2.05 Weight.
Interpretation: after the predicted 6MWD value from this retained equation is computed for an individual subject, for that subject the LLN may
be obtained by subtracting 74.31 m.
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those of previous studies with similar aims [11–17,19–24] (S3
Table), especially the Saudi and Italian ones [11,12] (S1 Table).
Ideally, norms are calculated with equations derived from
measurements observed in a representative sample of healthy
subjects in a general population [57]. Norms can also be
derived from large groups of volunteers provided that criteria
for normal selection and correct distribution of anthropomet-
ric characteristics are fulfilled [57]. In order to reduce the vol-
untary and selection bias, and as done by some authors [13,15],
all included subjects were questioned so that any non-inclusion
criteria would be identified. The included subjects were free
from chronic diseases, although 9.5% of them showed moder-
ate obesity or were underweight. Subjects with marked or
extreme obesity were not included [11,13,17,21,24] because it
is known that obese subjects with BMI > 35 kg/m2 tend to
walk slower [58] and it seems that specific 6MWD norms for
obese subjects are needed [59]. In addition, 9.1% of the
Algerian adults show obesity [60], and the present study group
composition reflected this ‘‘healthy” population as they exist in
the real population, increasing the external validity of the
retained norms. Therefore, the present study provides helpful
results for the analysis of 6MWD in North-African patients
aged 16–40 years suffering from chronic diseases.
Influencing factors
The independent contributors to 6MWD in the present study
population total sample were anthropometric (BMI, sex,
lean-mass, age), spirometric (FEV1) and physical activity data
(Table 3). A combination of a number of these factors has been
reported in previous studies including subjects aged 16–40 years[11–24]: BMI [14–16,19,20,22], sex [11,12,16,18,20,21,24], age
[11–16,18–22,24], FEV1 and FVC [14] and physical activity sta-
tus [14] (S3 Table). Other anthropometric factors (eg, height
[11–16,18–20,22,24] and weight [11,13,18–20,22,24]) and some
Hr parameters (eg, %Hrend [11] and DHr ‘‘ = Hrend-rest” [13])
or Borg value [11] were also reported as influencing factors
(S3 Table). Other factors, not evaluated in the present study,
may however have influenced 6MWD, such as socioeconomic
and/or schooling levels, diet habits, leg length, quadriceps force
and parity [10,31,33,61]. Anthropometric and spirometric data
were largely discussed in previous papers [4,9–36,59] and the
following sentences will consider the relationship between
6MWD and lean-mass, the physical activity level and Hr data.
Effect of the physical activity status on the 6MWD
Physical fitness is defined as characteristics enabling persons to
perform physical activity, with the health-related components
being cardiorespiratory endurance, muscle strength, muscle
endurance, flexibility and body composition [24,62].
Although physical inactivity may lead to increased risk of
long-term disability and co-morbidity [24,39], data about the
relationship between the physical activity status and the
6MWD of healthy adults are controversial [10,11,14–16,24–2
6,30,31,33]. In patients with chronic diseases, there were mod-
erate to strong relationships between 6MWD and objective
measures of physical activity (r= 0.38–0.85) [1]. The 6MWD
value of Algerians aged 16–40 years was 36 m greater in active
subjects when compared to non-active ones. In addition, MET
moderate activity was found to slightly (r= 0.18) but signif-
icantly contribute to the 6MWD variability’. The result is com-
parable to that found between reported physical activity [43]
6MWT data in North-African subjects aged 16–40 years 357and measured 6MWD (r= 0.25) in a sample aged 13–84 years
[14] or between physical activity score [63] and 6MWD
(r= 0.34) of healthy adults agedP 40 years [10]. Other stud-
ies including young adults [11,15,16] or middle-aged and
elderly subjects [25,30,31,33] found no significant correlations
between 6MWD and physical activity status evaluated by sev-
eral ways (lower extremities exercise activity [16,40], scores of
daily activity [33], self-reported physical activity including
habitual walking [25,41], physical activity level [42], regular
physical activity [25,31], habitual physical activity [15,43]).
For example, Gibbons et al. [16] found only a tendency
towards the difference between ‘‘active” and ‘‘inactive” sub-
jects. Discrepancy between results could be explained by the
different percentages of included subjects with a sedentary sta-
tus or having low physical activity scores: 82% [10], 80% [11],
79% [15], 73% (present study), 52% [14], 38% [16], 25% [24].
Another explanation could be the limited capacity of the
applied questionnaires’ – to describe a sedentary life style in
every one of its domains (e.g., amount and intensity of daily
physical activity) [64]. Further studies using movement sensors
are necessary.
Effect of lean-mass on the 6MWD
Although lean-mass is a predictor of exercise capacity in
healthy subjects [45] no previous study aiming to establish
norms in sample including healthy subjects aged 16–40 years
[9–36] have evaluated its relationship with 6MWD. At the best
of the authors’ knowledge, the present study is the first to
report a slight but significant contribution to the lean-mass
in the entire group 6MWD variability’: the lean-mass increase
of 1 kg increases 6MWD by 1.6 m (Table 3). It is known that a
higher amount of lean-mass observed in healthy whites has a
major impact on the 6MWD [13]. Similarly, a heavier subject
would need additional energy while ambulating to support
an enlarged weight (increase in adipose tissue rather than mus-
cle mass) and thereby curtailing the maximal level of effective
work [21]. However, 6MWD was similar in COPD with and
without lean-mass depletion, signifying that skeletal muscle
has a limited impact on 6MWD [46]. Specific studies on the
influence of lean-mass on 6MWD of healthy adults are needed.
Heart-rate response and sex-related difference
S4 Table exposes the adults Hr responses’ and sex-related dif-
ferences’ during the 6MWT which appeared to be mainly sub-
maximal, as reflected by a %Hrend of 72% (Table 2). This
finding is closer to that found in some studies [13,19] and
higher than that found in others [11,12,14,15,17] (S4 Table).
In contrast to some studies showing no sex-related difference
neither for Hrrest [13,15,19,24] nor for Hrend [13,15,19,24],
the present one Hrrest and Hrend mean values’ were signifi-
cantly higher in women vs. men (Table 2). This findings are
similar to those found in some studies for Hrrest [11–
13,17,21] or for Hrend [11,12,14,17,21] and confirm the sex-
related differences in Hr with increase in Hrrest [65,66] and in
Hrend [67] in women. One advanced explanation [12], was that
the baroreflex Hr regulation may be different between women
and men [68]. The significant positive correlation (r= 0.16)
found between the 6MWD and Hrrest data of Algerian subjects
aged 16–40 years (Table 2S) is similar to that observed inBrazilian [13] or Singaporean [31] or Australian [30] popula-
tions, with significant correlations between the 6MWD and
DHR (r= 0.43) [13] or %Hrend (r= 0.73 [31], r= 0.40 [30],
r= 0.29 [30]). Although the interference of Hr in the
6MWD has been suggested and considered important
[11–13,30,31], only some studies [13,30,31] have considered
these variables in the final 6MWD norms. Poh et al. [31] con-
sidered the %Hrend in the equation as well as age, height, and
weight and explained 78% of the 6MWD variability’. Jenkins
et al. [30] also included the %Hrend in the final equations as
well as age, height and BMI and explained 0.58 and 0.61 of
the Australian females and males 6MWD variability’s. Britto
et al. [13] considered the DHr in the equation as well as age,
sex and height and explained 0.62 of the Brazilian 6MWD
variability’. The use of Hr data as a parameter included in
the 6MWD norms is controversial. The introduction of %
Hrend in the equation may be limited when measuring the
6MWD in subjects with low fitness levels or with cardiac
impairment or medications which have an impact on mHr or
when symptoms such as dyspnoea or musculoskeletal pain
limit test performance [30,31]. However, according to Britto
et al. [13] the DHr use could in part neutralize this limitation.
This may happen since these diseases and medications interfere
not only in the Hrend but also in the Hrrest, and therefore
their influence on the DHr may be counterbalanced and
diminished [13].
Choice of the appropriate 6MWD reference equation
Significant differences between measured and predicted
6MWD from the mainly applied 6MWD norms [11,12] in
North-African subjects aged 16–40 years were noted (Fig. 1).
While the Italian norms [12] tend to significantly overestimate
the 6MWD, the Saudi ones [11] underestimate it. The implica-
tions of this for North-African subjects aged 16–40 years suf-
fering from chronic diseases may be considerable and include
potential errors relating to the level of patient disability and
improbable expectations of interventions intended to improve
6MWD [10]. This argues for the application of the present
study specific norms provided that the factor of altitude is
taken into account (Constantine being 649 m above sea level)
and confirms the international recommendation to carry on
establishing regional norm [1–3,38].
Guidelines recommend that norms be derived by suitable
and biologically significant statistical models taking into
account the dependence of the studied data with anthropo-
metric ones [1–3]. For only practical reasons, a single
6MWD norm including sex, BMI, age and weight as indepen-
dent variables was established. This norm still explained
58.7% of the 6MWD variability, which is very acceptable
compared with published norms including subjects aged 16–
40 years [11–17,19–24] [r2 varying from 0.20 [17] to 0.63
[19]] (S3 Table). In some studies [13,30,31], the mixture of
anthropometric and physiological (such as DHr or %Hrend)
data increases the r2 to 0.58 [30], to 0.61 [30], to 0.62 [13]
and to 0.78 [31]. Although the inclusion of such variables
amplified the amount of variance explained in 6MWD, this
result has limited relevance [30] since this measure is improb-
able to be a suitable indicator of an individual’s effort inten-
sity and is only obtainable on completion of the 6MWT
[30,31].
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At the best of the authors’ knowledge, among the published
6MWD norms including subjects aged 16–40 years [11–24],
only few studies [11,13,14] prospectively verified their validities
in a different group of healthy subjects (n= 58 [13], n= 58
[11], n= 85 [14]). The present study using additional prospec-
tive data confirmed the retained 6MWD norm’ reliability.
Interpretation of measured 6MWD
In order to facilitate the calculation of the 6MWT data,the
Excel software ‘‘6MWT for North-African subjects aged 16–
40 years” was developed (S1 file).
In addition to the use of tables of reference centile by age-
decade [23], two other approaches have been proposed to inter-
pret subjects 6MWD values’: LLN [14,19,20,22,24] or of a fixed
threshold (81% [15]) below which the 6MWD is considered
abnormal. In some studies [11–13,16–18,21], no interpreting
method was proposed. In subjects with prior confirmation of
cardiorespiratory and/or muscular diseases, a frontier low
6MWD value is more likely to be linked with disease; depend-
ing on the strength of medical evidence of disease, and the cost
and consequences of a centile (LLN) is clinically suitable [47].
The present study LLN was similar to that proposed by
Iwama et al. [14] and was lower than other reported values
(S3 Table). Therefore, given its high reliability, the present
study simplified norm is proposed to be used in North-
African subjects aged 16–40 years.
Recommendations
It is essential to perform a North-African multicenter study
[13,26] (with samples from Tunisia, Algeria, Morocco, Egypt
and Libya) including a large sample size (1000 males and
1000 females) with a large age range (six to 90 years old) [14]
and using a randomized sampling technique.
Conclusion
A reliable norm to interpret the 6MWD of healthy North-
African subjects aged 16–40 years was established. The
6MWD can be simply predicted from sex, BMI, age and weight.
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